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1. Introduction  
In the search for sustainable catalytic methodologies, 
replacement of precious metals with base metals is receiving 
increasing attention by academic and industrial researchers. 
However, as far as homogeneous catalysis is concerned, the 
choice of the ligand is equally important as that of the metal. 
Indeed, use of costly and sophisticated ligands may offset the 
intrinsic advantage of employing a cheap metal. 
(Cyclopentadienone)iron complexes 1 (Scheme 1) represent a 
good balance between these two aspects because they combine 
iron – i.e., the cheapest, most abundant and least toxic transition 
metal [ 1 ] – with simple ligands such as CO and 
cyclopentadienones. The latter are readily prepared by 
condensation of α-diketones with 1,3-disubstituted acetones or by 
cyclative carbonylation/complexation of diynes (directly 
affording the iron complexes) [2]. Additionally, unlike many 
other iron complexes used in catalysis, compounds 1 are very 
stable, which facilitates their purification (that can be performed 
by chromatography) and use. Under suitable conditions (Scheme 
1 A) they can be converted in situ into the activated forms act-1 
and 2 [3], which promote several reactions involving hydrogen 
transfer through the same pericyclic transition state (Scheme 1 
B): i) reduction of polar double bonds by catalytic hydrogenation 
[3d-g,4a,c-f,5] or catalytic transfer hydrogenation [3a,4a-b,6]; ii) 
Oppenauer-type oxidation of alcohols [6b,e,7]; iii) redox-neutral 
hydrogen-borrowing reactions such as alcohol amination [8] and 
others [8a,9]. 
 
Scheme 1. A: in situ activation of (cyclopentadienone)iron complexes 1; B: 
TS of the reactions involving transfer of hydrogen promoted by the active 
complexes act-1 and 2.  
 
Very recently, the first applications of 
(cyclopentadienone)iron complexes to reactions not involving 
hydrogen transfer have also appeared in the literature [10]. 
Despite the blossoming interest for these complexes, their use 
in enantioselective catalysis is still very limited, with the notable 
exception of the enantioselective C=N reductions reported by 
ART ICLE  INFO  AB ST R ACT  
Article history: 
Received 
Received in revised form 
Accepted 
Available online 
In this paper, we describe a small library of easy-to-prepare chiral (cyclopentadienone)iron pre-
catalysts for enantioselective C=O and C=N hydrogenations. Starting from readily accessible 
achiral materials, six chiral (cyclopentadienone)iron complexes (1a-f) possessing a stereogenic 
plane were synthesized in racemic form. Based on the screening of pre-catalysts (±)-1a-f in the 
hydrogenation of ketones and ketimines, we selected two complexes (1a and 1d) for resolution 
by semipreparative enantioselective HPLC. The absolute configuration of the separated 
enantiomers of 1a and 1d was assigned by XRD analysis (1a) and by comparison between 
experimental and DFT-calculated ECD and ORD spectra (1d). The enantiopure pre-catalysts 
(S)-1a and (R)-1d were tested in the asymmetric hydrogenation of several ketones and ketimines 
and showed good activity and modest enantioselectivity, the e.e. values ranging from very low 
to moderate (54%). 
2009 Elsevier Ltd. All rights reserved. 
 
Keywords: 
Asymmetric hydrogenation 
(Cyclopentadienone)iron complexes 
Iron catalysis 
Stereogenic plane 
Polar double bonds 
 
 2 
Beller et al., in which an achiral type-2 complex (i.e., the air-
sensitive activated form) is combined with a chiral phosphoric 
acid co-catalyst [3d-g]. Attempts to develop effective chiral type-
1 pre-catalysts met with only partial success, with poor or 
moderate e.e.’s obtained in the reduction of ketones and 
ketimines (Fig. 1). This is probably due to the difficulty to place 
the stereogenic group(s) of the complexes sufficiently close to 
the substrate in the pericyclic TS of reductions (see Scheme 1 B). 
 
Fig. 1. Main strategies for synthesis of chiral (cyclopentadienone)iron 
complexes. AH = asymmetric hydrogenation; ATH = asymmetric transfer 
hydrogenation. 
 
For the synthesis of chiral (cyclopentadienone)iron 
complexes, two main strategies have been employed so far: the 
first, developed by Berkessel and co-workers (Fig. 1 A), consists 
in replacing a CO ligand of an achiral complex with a chiral 
monodentate ligand [11]. The second, followed by Wills et al. 
[6a,c,d,f], by Ward/Renaud et al. [12] and by our research group 
[4a,e,f], involves the use of a chiral cyclopentadienone ligand 
(Fig. 1 B) [13]. Attempts to merge these two approaches – i.e., 
introducing a chiral monodentate ligand into a chiral 
cyclopentadienone complex – did not lead to appreciable 
improvements in terms of enantioselectivity [2a,6c]. 
A third possible strategy, recently applied by Hayashi and co-
workers to the synthesis of chiral Shvo-type ruthenium 
complexes [14], involves the use of achiral cyclopentadienones 
bearing different substituents on the two sides of the C=O group 
to synthesize chiral complexes possessing a stereogenic plane 
(Fig. 1 C). This paper accounts for our efforts in this direction, 
with the synthesis of six new chiral iron complexes, two of which 
were resolved in the pure enantiomeric forms and tested in the 
asymmetric hydrogenation (AH) of ketones and ketimines. 
2. Results and discussion 
2.1. Synthesis of the racemic complexes and test of their 
catalytic activity  
In the ligand design, we decided to employ cyclopentadienone 
ligands featuring the biggest possible difference, in steric and/or 
stereoelectronic terms, between the substituents at C2 and C5. 
Indeed, in the commonly accepted TS of the reductions promoted 
by complexes 1 (Scheme 1 B), the 2,5-substituents are relatively 
close to the approaching substrate. 
We started with the preparation of complex (±)-1a – featuring 
the same cyclopentadienone ligand as one of the Hayashi’s Ru-
complexes – by reacting Fe2(CO)9 with the known 
cyclopentadienone 4 [14] (Scheme 2). The latter compound, in 
turn, was readily synthesized by condensation of benzil with 1-
phenyl-2-butanone (3), prepared as described in the literature 
[14,15]. 
 
 
Scheme 2. Synthesis of the racemic (cyclopentadienone)iron complex (±)-1a. 
 
Next, starting from a common precursor (commercially 
available 1,7-octadiyne), we synthesized five racemic 
(cyclopentadienone)iron complexes featuring different 
substituents at C2 and C5 (Scheme 3). Following a literature 
procedure [16], 1,7-octadiyne was treated with LiHMDS and 
trimethylsilyl chloride to yield compound 5, bearing a 
trimethylsilyl (TMS) at one of its terminal alkyne groups. The 
remaining C-terminus was functionalized in two different ways: 
i) with a phenyl group (by Sonogashira coupling), yielding the 
asymmetric diyne 6 [ 17 ]; ii) with a methyl group, giving 
compound 7 [16]. The latter was either used directly for iron 
complexation or de-silylated with K2CO3 to yield diyne 8 [18], 
whose terminal alkyne group was functionalized with a 
triethylsilyl (TES) or a triisopropylsilyl (TIPS) or a trityl group 
yielding diynes 9, 10 and 11, respectively. Treatment of diynes 6-
7 and 9-11 with Fe2(CO)9 in toluene at 110 °C gave the racemic 
complexes (±)-1b-f in yields ranging from 13% to 60%. 
The catalytic activity of the newly synthesized complexes (±)-
1a-f, activated in situ with Me3NO, in the hydrogenation of polar 
double bonds was tested using acetophenone (S1) and (E)-N-(4-
methoxyphenyl)-1-phenylethan-1-imine (S2) as model substrates 
(Table 1). Pre-catalysts (±)-1a and (±)-1b gave high conversion 
of S1 and S2 at both 5 mol% and 2 mol% loading (Table 1, 
entries 1-4). Along the series (±)-1c → (±)-1f, conversions were 
found to decrease with the increasing size of the “large” 
substituent RL (Table 1, entries 5-12): while (±)-1c (RL = TMS) 
and (±)-1d (RL = TES) gave full conversion of S1 and acceptable 
conversions of S2 (entries 5-8), the activity of (±)-1e (RL = TIPS) 
and (±)-1f (RL = CPh3) decreased dramatically (entries 9-12). 
Complex 1d features the largest possible RL compatible with an 
acceptable catalytic activity, and for this reason it was selected 
for enantiomer separation. Moreover, it was decided to resolve 
also complex 1a which, besides being the most active of the 
group, allows to establish a comparison with the corresponding 
ruthenium complex developed by Hayashi and co-workers [14].  
 3 
 
Scheme 3. A: Synthesis of the asymmetric diynes 5-11; B: Synthesis of the racemic (cyclopentadienone)iron complexes (±)-1b-f. 
 
Table 1 
Test of the activity of the racemic complexes (±)-1a-f in C=O and C=N 
hydrogenation.a 
 
Entry Pre-cat. Loading (mol%) Conv. S1 (%)b Conv. S2 (%)b 
1 1a 2 > 99 > 99 
2 1a 5 > 99 > 99 
3 1b 2 > 99 89 
4 1b 5 > 99 > 99 
5 1c 2 > 99 69 
6 1c 5 > 99 82 
7 1d 2 > 99 4 
8 1d 5 > 99 92 
9 1e 2 73 8 
10 1e 5 76 62 
11 1f 2 0 12 
12 1f 5 35 18 
a Reaction conditions: Pre-cat./Me3NO = 1:2, T = 80 °C, PH2 = 50 bar, 22 h. 
C0,sub. = 0.5 M. 
b Determined by 1H NMR. 
 
2.2. Resolution of complexes 1a and 1d by semipreparative 
enantioselective HPLC and determination of the absolute 
configuration of the enantiomerically pure complexes 
The racemic complexes (±)-1a and (±)-1d were resolved by 
enantioselective HPLC. More in detail, the enantiomers of (±)-1a 
were resolved on the (R,R)-DACH-DNB chiral stationary phase 
(CSP) under normal phase conditions (mobile phase: n-
hexane/DCM 80:20 + 2% MeOH v/v), using both UV and ECD 
detection (k’1 = 2.36; α = 1.27; T = 25 °C, see Fig. 2 A).  
 
 
Fig. 2. Analytical separation of racemic mixtures (±)-1a (A) and (±)-1d (B) 
by enantioselective HPLC. A) column: (R,R)-DACH-DNB 5 µm (250 mm × 
4.6 mm L. × I.D.); eluent: n-hexane/DCM 80:20 + 2% MeOH v/v; flow rate 
1.0 mL/min at 25 °C. B) column: Chiralpak IC 5 µm (250 mm × 4.6 mm L.× 
I.D.); eluent: n-hexane/IPA 95:5 v/v; flow rate 1.0 mL/min at 25 °C. 
 
The separation was then scaled-up to semipreparative conditions, 
with 60 replicate separations (2 mg of sample injected in each 
run) carried out on a 1.0 cm internal diameter (R,R)-DACH-DNB 
column. This provided the two enantiomers with an overall 
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recovery of 80%. The e.e. values of the first and second eluted 
enantiomer – determined by analytical HPLC with UV and ECD 
detection at 300 nm – were 99% and 98%, respectively (see the 
Supplementary data). As for complex (±)-1d, the enantiomers 
were separated on a Chiralpak IC CSP column (mobile phase: n-
hexane/IPA 95:5 v/v), achieving an α value of 1.37 (k’1 = 2.84, 
Figure 2 B). In the semipreparative scale-up stage, each 
enantiomer (70 mg, process yield = 79%) was obtained with an 
enantiomeric excess of 99%, measured by analytical HPLC with 
UV and CD detection at 270 nm (see the Supplementary data). 
After the successful resolution of complexes 1a and 1d, we set to 
assign the absolute configuration (AC) of the separated 
enantiomers [19 ]. In the absence of configurationally known 
reference compounds which can be correlated to the chiral 
analyte, X-ray diffraction (XRD) analysis represents the first-
choice method for AC assignment [20].  Suitable crystals of the 
first-eluted enantiomer of complex 1a were obtained by vapor 
diffusion of pentane into a DCM solution of the complex, 
followed by cooling (-18 °C). Diffractometric analysis of a single 
crystal showed that the absolute configuration of this enantiomer, 
assigned according to the extended CIP rules [21], is S (Fig. 3, 
additional details are reported in the Supplementary data). 
As no crystals could be grown for the enantiomerically pure 
forms of complex 1d, the AC was assigned by a 
spectroscopic/computational procedure [ 22 ]. The electronic 
circular dichroism (ECD) and optical rotation dispersion (ORD) 
spectra were registered for each of the separated enantiomers and 
compared to the equivalent spectra simulated by DFT 
calculations for the R enantiomer (see details in Section 4.8). 
From inspection of the superimposed spectra (shown in Fig. 4), a 
good matching was found between the spectra of the first-eluted 
enantiomer and the calculated one. Thus, R configuration was 
assigned to the first-eluted enantiomer of 1d, and S configuration 
to the second eluted one. 
 
 
Fig. 4. ECD and ORD experimental spectra of the resolved enantiomers of 1d 
superimposed to the equivalent ones simulated through DFT calculations for 
the R enantiomer. 
 
 
Fig 3. X-Ray crystal structure of the first-eluted enantiomer (S) of complex 1a. Color codes: Fe, orange; O, red; C, gray; H, white. Selected bond distances: Fe-
C1B, 1.802(2); Fe-C1A, 1.804(2); Fe-C1C, 1.804(2); Fe-C4, 2.0721(16); Fe-C3, 2.0830(16); Fe-C5, 2.1222(18); Fe-C2, 2.1389(17). 
 
2.3. Test of the enantiomerically pure complexes in the AH of 
ketones and ketimines 
The enantiomerically pure complexes (S)-1a and (R)-1d were 
tested in the AH of several ketones, giving the results shown in 
Table 2. The complexes confirmed to be quite active pre-
catalysts, giving always full conversion except in two cases 
[Table 2, entries 3 and 4 with pre-catalyst (S)-1a]. Unfortunately, 
only low enantioselectivity was obtained with substrates S1, S4, 
S5 and S6 (Table 2, entries 1, 3-5), whereas 2,2,2-trifluoro-1-
phenylethan-1-one S3 was reduced with moderate e.e. values 
(entry 2). Notably, the sense of stereoinduction was different 
with the two pre-catalysts, consistent with the assigned opposite 
configurations (see Section 2.2). 
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Table 2 
AH of ketones promoted by the chiral pre-catalysts (S)-1a and (R)-1d.a 
R1 R2
O
R1

R2
OH
H2 (50 bar)
Pre-Cat. (5 mol%)
Me3NO (10 mol%)
COOCOC
Fe
COOCOC
O
Me
Ph
Ph
Ph
(S)-1a (R)-1d
iPrOH, 80 °C, 22 h
S P
Fe
O
SiEt3
Me
 
Entry Substrate 
Pre-catalyst (S)-1a Pre-catalyst (R)-1d 
Conv. (%)b e.e. (%)b Conv. (%)b e.e. (%)b 
1c 
 
> 99 [99]d 3, R > 99 [99]d 9, R 
2c 
 
> 99 [98]d 45, R > 99 [98]d 41, S 
3c 
 
36 [33]d 9, S > 99 [99]d 9,  R 
4c 
 
73 [72]d 13, S > 99 [99]d 18, R 
5e 
 
> 99 [85]d 14, S > 99 [99]d 18, S 
a Reaction conditions: Substrate/Me3NO/Pre-cat. = 100:10:5, T = 80 °C, PH2 = 
50 bar, 22 h. C0,sub. = 0.5 M. 
b Determined by GC analysis with a chiral capillary column. 
c Absolute configuration of the product assigned by comparing the order of 
elution with literature data (see the experimental section). 
d Isolated yield. 
e Absolute configuration of the product assigned by comparing the sign of 
optical rotation with literature data (see the experimental section). 
 
Table 3 
AH of ketimines promoted by the chiral pre-catalysts (S)-1a and (R)-1d.a 
R1 R2
N
R1

R2
HN
H2 (50 bar)
Pre-Cat. (5 mol%)
Me3NO (10 mol%)
Fe
COOCOC
Fe
COOCOC
O
Me
Ph
Ph
Ph
(S)-1a (R)-1d
iPrOH, 80 °C, 22 h
R3 R3
S P
O
SiEt3
Me
 
Entry Substrate 
Pre-catalyst (S)-1a Pre-catalyst (R)-1d 
Conv. (%)b e.e. (%)c Conv. (%)b e.e. (%)c 
1d 
 
> 99 [98]e 40, R 96 [96]e 39, S 
2f 
 
97 [91]e 29, R 91 [78]e 6, S 
3f 
 
> 99 [76]e 54, R 65 [41]e 40, S 
4f 
 
76 [57]e 18, S 73 [48]e 6, R 
a Reaction conditions: Substrate/Me3NO/Pre-cat. = 100:10:5, T = 80 °C, PH2 = 
50 bar, 22 h. C0,sub. = 0.5 M. 
b Determined by 1H NMR. 
c Determined by enantioselective HPLC. 
d Absolute configuration of the product assigned by comparing the sign of 
optical rotation with literature data (see the experimental section). 
e Isolated yield. 
f Absolute configuration assigned by comparing the order of elution with 
literature data (see the experimental section). 
 
Complexes (S)-1a and (R)-1d were screened also in the AH 
of several N-PMP ketimines, showing again good activity: 
conversions were high (> 90%) in most cases, and reasonable in 
the remaining ones [Table 3, entry 3 with (R)-1d and entry 4]. 
Moderate e.e. values were achieved with the acetophenone- and 
the propiophenone-derived imines S2 and S8 (Table 3, entries 1 
and 3), (S)-1a being slightly more enantioselective than (R)-1d. 
Imines S7 and S9 were hydrogenated with a low level of 
stereoselectivity, somewhat higher with (S)-1a than with (R)-1d 
(Table 3, entries 2 and 4). With all ketimines, the two pre-
catalysts showed opposite stereochemical preferences. 
3. Conclusion  
The work described in this paper aims at developing easy-to-
prepare chiral (cyclopentadienone)iron pre-catalysts for 
enantioselective reductions. Starting from readily accessible 
achiral materials, six chiral (cyclopentadienone)iron complexes 
(1a-f) possessing a stereogenic plane were synthesized in racemic 
form. To enhance the enantiodiscrimination, pre-catalyst were 
designed to maximize the difference – in terms of steric and 
stereoelectronic properties – between the substituents at position 
2 and 5 of the cyclopentadienone ring (which are close to the 
substrate in the hydrogenation TS). Unfortunately, catalytic tests 
carried out with the racemic complexes (±)-1a-f revealed that the 
increasing the size of the ‘large’ substituent RL beyond a certain 
extent leads to a drop of catalytic activity. The best compromise 
between RL size and catalytic activity was reached with 
complexes 1a and 1d, which were resolved by semipreparative 
enantioselective HPLC. The absolute configuration of the two 
enantiomeric forms of complex 1a was assigned on the basis of 
XRD analysis of the first-eluted enantiomer (S). For complex 1d, 
the assignment was made by comparing the ORD and ECD 
spectra of the two enantiomers with the equivalent spectra 
simulated by DFT calculations for the R enantiomer. The 
enantiomerically pure complex (S)-1a promoted the AH of 
ketones and ketimines with low to moderate enantioselectivity, 
similar to that obtained with its ruthenium analog developed by 
Hayashi and co-workers [14]. To our surprise, the larger RL 
group present in pre-catalyst (R)-1d was not sufficient to enhance 
the enantiocontrol. Overall, these results confirm that an effective 
chiral (cyclopentadienone)iron pre-catalyst for enantioselctive 
reduction still represents a distant goal. However, we believe that 
the catalyst design adopted here, involving a short and 
straightforward synthetic route starting from cheap precursors, 
will provide useful directions for the future. 
 
4. Experimental Section 
4.1. General information 
All reactions were carried out in flame-dried glassware with 
magnetic stirring under inert atmosphere (nitrogen or argon), 
unless otherwise stated. Solvents for reactions were distilled over 
the following drying agents and transferred under nitrogen: THF 
(Na), toluene (Na). Dry N,N-dimethylformamide (DMF, over 
molecular sieves in bottles with crown cap) was purchased from 
Sigma Aldrich and stored under nitrogen. All reagents were used 
without purification. Known compounds 3 [15], 4 [14], 5 [16], 6 
[17], 7 [16] and 8 [18] were prepared following slightly modified 
literature procedures (see the Supplementary data). Imines S2 
and S7-S9 were prepared as previously described [4a,b]. 
Reactions were monitored by analytical thin-layer 
chromatography (TLC) using silica gel 60 F254 pre-coated glass 
plates (0.25 mm thickness). Visualization was accomplished by 
irradiation with a UV lamp and/or staining with a potassium 
permanganate alkaline solution. Flash Column Chromatography 
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(FCC) was performed using silica gel (60 Å, particle size 40-64 
μm) as stationary phase, following the procedure by Still and co-
workers [23]. Optical rotations were measured with a Jasco-P-
2000 digital polarimeter at 20 or 22 °C, and concentrations (c) 
are given in g / 100 mL. 1H-NMR spectra were recorded on a 
spectrometer operating at 400.13 MHz. Proton chemical shifts 
are reported in ppm (δ) with the solvent reference relative to 
tetramethylsilane (TMS) employed as the internal standard 
(CDCl3, δ = 7.26 ppm; CD2Cl2 δ = 5.32 ppm). The following 
abbreviations are used to describe spin multiplicity: s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet. 13C-NMR spectra 
were recorded on a 400 MHz spectrometer operating at 100.56 
MHz, with complete proton decoupling. Carbon chemical shifts 
are reported in ppm (δ) relative to TMS with the respective 
solvent resonance as the internal standard (CDCl3 δ = 77.16 ppm; 
CD2Cl2 δ = 54.00 ppm). The coupling constant values are given 
in Hz. Infrared spectra were recorded on a standard FT/IR 
spectrometer. Melting points were recorded with a standard 
melting-point apparatus. High resolution mass spectra (HRMS) 
were performed on a ESI QTof SYNAPT G2 Si mass 
spectrometer (Waters), available at the UNITECH-COSPECT 
laboratories (Università degli Studi di Milano). Elemental 
analyses were performed on a Perkin Elmer Series II CHNS/O 
Analyzer 2000. X-ray intensity data were collected with a Bruker 
AXS APEXII CCD area detector by using graphite 
monochromated Mo-Kα radiation. 
4.2. Complex (±)-1a 
In a Schlenk tube fitted with a Teflon-topped screw cap, 
Fe2(CO)9 (1.1284 g, 3.102 mmol) was added to a stirred solution 
of cyclopentadienone 3 (500 mg, 1.551 mmol) in toluene (10 
mL). The reaction mixture was heated to 110°C and stirred for 16 
hours. The reaction mixture was cooled down to room 
temperature and filtered through Celite (rinsing with AcOEt). 
After removal of the solvent, the residue was purified by flash 
column chromatograph (9:1 hexane/AcOEt) to afford the product 
as a light yellow solid. Yield: 628 mg (88%). M.p. = 199.1 °C; 
1H-NMR (400 MHz, CD2Cl2) δ 7.52-7.49 (m, 2H), 7.41-7.33 (m, 
5H), 7.28-7.23 (m, 4H), 7.16-7.15 (m, 4H), 1.94(s, 3H); 13C-
NMR (100 MHz, CD2Cl2) δ209.52, 171.68, 132.28, 132.02, 
131.93, 130.96, 130.66, 130.49, 129.39, 129.18, 128.79, 128.55, 
128.49, 128.44, 128.33, 105.35, 104.93, 83.63, 80.60, 10.81; IR 
(film): ν = 3058.6, 2922.6, 2855.1, 2062.5, 1991.1, 1641.1, 
1577.5, 1499.4, 1445.4, 1390.4, 1171.5, 1073.2, 1029.8, 1003.8, 
927.6, 853.3, 769.5, 757.9, 853.3, 76935, 757.9, 736.7, 698.1, 
666.3, 645.1, 613.3 cm-1; HRMS (ESI+): m/z 463.0631 [M+H]+ 
(calcd. for C32H27FeO4: 463.0633). 
4.3. Triethyl(nona-1,7-diyn-1-yl)silane (9) 
nBuLi (1.6 M in hexanes, 2.29 mL, 3.661 mmol) was added 
dropwise to a stirred solution of diyne 8 (400 mg, 3.328 mmol) in 
THF (22 mL) at -78 °C. After stirring for 1 hour at -78 °C, TES-
Cl (601.9 mg, 3.9936 mmol) was added and the mixture was 
stirred at -78 °C for 1 h before being allowed to warm to room 
temperature overnight. The reaction was quenched using 
saturated sat. aq. NH4Cl (25 mL) and extracted with Et2O (3 × 25 
mL). The combined organic extracts were dried over MgSO4 and 
the solvent was removed in vacuo. The residue was purified by 
flash column chromatograph (98:2 hexane/AcOEt) to afford the 
pure product as a light yellow oil. Yield: 733 mg (94%). 1H-
NMR (400 MHz, CDCl3): 2.25 (t, J = 6.80 Hz, 2H), 2.15-2.12 
(m, 2H), 1.76 (t, J = 2.56 Hz, 3H), 1.61-1.57 (m, 4H), 0.97 (t, J = 
7.96 Hz, 9H), 0.59 (q, J1 = 7.84 Hz, J2 = 15.80 Hz, 6H); 
13C-
NMR (100 MHz, CDCl3): 108.38, 81.80, 78.92, 75.77, 28.18, 
27.99, 19.57, 18.37, 7.58, 4.69, 3.55; IR (film): ν = 3585.0, 
2953.5, 2916.8, 2874.4, 2733.6, 2172.4, 1655.6, 1458.9, 1414.5, 
1377.9, 1326.8, 1260.3, 1236.2, 1096.3, 1017.3, 973.9, 930.5, 
842.7, 806.1, 736.7, 726.1 cm-1; MS (ESI +) m/z 257.51 [M + 
Na]+ (calcd. for C15H26SiNa: 257.17); elemental analysis (%): C 
75.60, H 11.01, (calcd. for C15H26Si: C 76.84, H 11.18). 
4.4. Triisopropyl(nona-1,7-diyn-1-yl)silane (10) 
nBuLi (1.6 M in hexanes, 2.29 mL, 3.661 mmol) was added 
dropwise to a stirred solution of diyne 8 (400 mg, 3.328 mmol) in 
THF (22 mL) at -78 °C. After stirring for 1 hour at -78 °C, TIPS-
Cl (770 mg, 3.9936 mmol) was added and the mixture was stirred 
at -78 °C for 1 h before being allowed to warm to room 
temperature overnight. The reaction was quenched using 
saturated sat. aq. NH4Cl (25 mL) and extracted with Et2O (3 × 25 
mL). The combined organic extracts were dried over MgSO4 and 
the solvent was removed in vacuo. The residue was purified by 
flash column chromatograph (98:2 hexane/AcOEt) to afford the 
pure product as a light yellow oil. Yield: 1.167 g (95%). 1H-
NMR (400MHz, CDCl3): 2.28-2.24 (m, 2H), 2.15-2.13 (m, 2H), 
1.76 (t, J = 2.60 Hz 3H), 1.62-1.60 (m, 4H), 1.07-1.02 (m, 21H); 
13C-NMR (100 MHz, CDCl3): 108.89, 80.41, 78.92, 75.75, 28.13, 
28.06, 19.53, 18.75, 18.34, 11.45, 3.55; IR (film): ν = 3584.1, 
2942.8, 2892.7, 2865.7, 2724.0, 2171.5, 1639.2, 1462.7, 1383.7, 
1366.3, 1326.8, 1242.9, 1071.3, 1016.3, 995.1, 919.9, 883.2, 
702.0, 676.9, 660.5, 621.0 cm-1; elemental analysis (%): C 71.21, 
H 11.05, (calcd. for C18H32Si: C 78.18, H 11.66).  
4.5. Deca-2,8-diyne-1,1,1-triyltribenzene (11) 
In a Schlenk tube at 0 °C, a solution of ethylmagnesium 
bromide (2 M in THF, 4.1 mL, 8.33 mmol) was added dropwise 
to a stirred solution of compound 8 (1g, 8.33 mmol) and THF (11 
mL). The resulting mixture was heated to reflux and stirred for 1 
h. After cooling down to room temperature, trityl chloride (2.322 
g, 8.33 mmol) was added. The resulting mixture was heated to 
reflux and stirred overnight. After cooling down to room 
temperature, the reaction was quenched with sat. aq. NH4Cl (15 
mL), and the obtained aqueous phase was extracted with AcOEt 
(3 × 30 mL). The organic layer was washed with water (25 mL) 
and brine (25 mL), dried over Na2SO4 and concentrated in vacuo. 
The crude product was purified by column chromatography on 
silica gel (9:1 hexane/AcOEt) to give the product as a white 
solid. Yield: 1.61 g (53%). M.p. = 85.2 °C; 1H-NMR (400MHz, 
CD2Cl2): 7.31-7.25 (m, 15H), 2.41 (t, J = 6.72 Hz, 2H), 2.20-2.15 
(m, 2H), 1.77 (t, J = 2.56 Hz, 3H), 1.72-1.63 (m, 4H); 13C-NMR 
(100MHz, CD2Cl2): 146.48, 129.65, 128.44, 127.21, 86.73, 
86.17,  79.25, 76.07, 56.17, 28.94, 28.59, 19.10, 18.78, 3.73; IR 
(film): ν = 3584.1, 3083.6, 3058.6, 3021.9, 2939.0, 2859.0, 
1951.6, 1595.8, 1489.7, 1445.4, 1328.7, 1182.2, 1077.1, 1032.7, 
1001.8, 891.0, 746.3, 689.1, 638.3, 618.1 cm-1; MS (ESI +) m/z 
363.52 [M + H]+ (calcd. for C28H26: 363.52); elemental analysis 
(%): C 92.77, H 7.22, (calcd. for C28H26: C 92.77, H 7.23). 
4.6. General procedure for the synthesis of complexes (±)-1b-f 
In a Schlenk tube fitted with a Teflon-topped screw cap, 
distilled toluene (6 mL) was added to a mixture of the diyne 
(0.853 mmol) and Fe2(CO)9 (621 mg, 1.706 mmol). The mixture 
was heated to 110 °C and stirred overnight. After cooling down 
to room temperature, the products were purified by column 
chromatography (4:1 hexane/AcOEt) to afford the pure iron 
complexes. 
4.6 .1 .  Complex (±) -1b  
Prepared from diyne 6 according to the General procedure. 
Yield: 216 mg (60%). M.p. = 117.8 °C; 1H-NMR (400 MHz, 
CD2Cl2): 7.65-7.62 (m, 2H), 7.38-7.31 (m, 3H), 2.71-2.68 (m, 
2H), 2.65-2.55 (m, 2H), 1.91-1.84 (m, 4H), 0.32 (s, 9H); 13C-
NMR (100 MHz, CD2Cl2): 209.86, 175.84, 132.51, 130.19, 
128.76, 128.20, 107.37, 106.12, 85.16, 68.79, 60.05, 24.87, 
24.85, 22.88, 22.82, 0.01; IR (film): ν = 2949.6, 2852.2, 2057.7, 
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1998.9, 1632.5, 1501.3, 1442.5, 1403.0, 1247.7, 1181.2, 1152.3, 
1017.3, 892.0, 838.9, 757.9, 695.2, 617.1 cm-1; HRMS (ESI+): 
m/z 423.0708 [M+H]+ (calcd. for C32H27FeO4: 423.0715). 
4.6 .2 .  Complex (±) -1c  
Prepared from diyne 7 according to the General procedure. 
Yield: 61.4 mg (25%). M.p. = 74.4 °C; 1H-NMR (400 MHz, 
CD2Cl2): 2.57-2.43 (m, 4H), 1.84-1.81 (m, 4H), 1.68 (s, 3H), 0.26 
(s, 9H); 13C-NMR (100 MHz, CD2Cl2): 210.10, 176.89, 107.04, 
81.98, 68.47, 24.81, 23.07, 22.59, 22.43, 8.87, 0.04; IR (film): ν 
= 2950.6, 2056.7, 1996.0, 1635.3, 1447.3, 1247.7, 1087.7, 845.6, 
761.7, 698.1, 654.7, 618.1 cm-1; HRMS (ESI+): m/z 361.0552 
[M+H]+ (calcd. for C32H27FeO4: 361.0559). 
4.6 .3 .  Complex (±) -1d  
Prepared from diyne 9 according to the General procedure. 
Yield: 90.7 mg (25%). M.p. = 58.5 °C; 1H-NMR (400 MHz, 
CD2Cl2): 2.52-2.47 (m, 4H), 1.84-1.79 (m, 4H), 1.64 (s, 3H), 1.01 
(t, J = 7.84 Hz, 9H), 0.88-0.81 (m, 6H); 13C-NMR (100 MHz, 
CD2Cl2): 210.10, 176.82, 107.28, 107.17, 82.08, 67.19, 25.36, 
23.15, 22.54, 22.43, 8.91, 7.91, 4.36; IR (film): ν = 2951.5, 
2874.4, 2056.7, 1996.0, 1979.6, 1636.3, 1446.4, 1293.0, 1240.0, 
1143.6, 1004.7, 784.9, 732.8, 699.1, 617.1 cm-1; HRMS (ESI+): 
calcd. for C19H27FeO4Si [M+H], found. HRMS (ESI+): m/z 
403.1018 [M+H]+ (calcd. for C32H27FeO4: 403.1028). 
4.6 .4 .  Complex (±) -1e  
Prepared from diyne 10 according to the General procedure. 
Yield: 49.3 mg (13%). M.p. = 86.4 °C; 1H-NMR (400 MHz, 
CD2Cl2): 2.60-2.52 (m, 4H), 1.88-1.78 (m, 4H), 1.64 (s, 3H), 
1.49-1.41 (m, 3H), 1.16 (t, J = 7.88 Hz, 18H); 13C-NMR (100 
MHz, CD2Cl2): 210.12, 176.55, 107.96, 106.46, 81.60, 69.92, 
26.28, 23.43, 22.42, 22.40, 19.85, 19.82, 18.99, 13.10, 8.96; IR 
(film): ν = 2945.7, 2865.7, 2057.7, 1997.9, 1980.5, 1632.5, 
1446.4, 1385.6, 1365.4, 1289.2, 1254.5, 1139.7, 1070.3, 1021.1, 
881.3, 729.0, 687.5, 665.3, 618.1 cm-1; HRMS (ESI+): HRMS 
(ESI+): m/z 445.1493 [M+H]+ (calcd. for C32H27FeO4: 445.1498). 
4.6 .5 .  Complex (±) -1f  
Prepared from diyne 11 according to the General procedure. 
Yield: 149.3 mg (33%). M.p. = 90.8 °C; 1H-NMR (400 MHz, 
CD2Cl2): 7.25-7.16 (m, 15H), 2.60-2.51 (m, 2H), 1.81-1.70 (m, 
2H), 1.63 (s, 3H), 1.56-1.46 (m, 2H), 1.30-1.19 (m, 2H); 13C-
NMR (100 MHz, CD2Cl2): 210.39, 174.29, 146.61, 131.80, 
127.83, 127.10, 104.03, 101.74, 95.58, 78.84, 60.61, 24.21, 
23.75, 22.67, 21.86, 8.94; IR (film): ν = 3057.6, 2932.2, 2054.8, 
1994.0, 1647.9, 1491.7, 1445.4, 1034.6, 854.3, 755.0, 736.7, 
699.1, 613.3 cm-1; HRMS (ESI+): m/z 531.1254 [M+H]+ (calcd. 
for C32H27FeO4: 531.1259). 
4.7. Resolution of complexes 1a and 1d by chiral semipreparative 
HPLC and ECD spectra registration 
The analytical liquid chromatography was performed on an 
HPLC equipped with a Rheodyne model 7725i 20 μL loop 
injector, a PU-1580-CO2 and PU-980 Jasco HPLC pumps, a UV 
detector Jasco-975, and a circular dichroism detector Jasco 995-
CD. Chromatographic data were collected and processed using 
Borwin software (Jasco Europe, Italy). The semipreparative 
liquid chromatography was performed on a Waters 
chromatograph (WatersAssociates) equipped with a 200 µL loop 
injector, a UV SpectroMonitor 4100 spectrophotometer, and a 
refractive index detector. Racemic complex (±)-1a were resolved 
by semipreparative HPLC, using a (R,R)-DACH-DNB column 
(250 mm × 10 mm L. × I.D.), a mixture of n-hexane/DCM 80:20 
+ 2% MeOH v/v was employed as eluent (flow rate 4.0 mL/min 
and Tcol. = 25 °C). The sample of (±)-1a was dissolved in the 
mobile phase (c = 20 mg/mL); each injection was 100 µL 
(process yield 80%). The enantiomeric excess, the UV, and 
ECD at 300 nm were determined by analytical HPLC with use of 
a Regis (R,R)-DACH-DNB column (250 mm × 4.6 mm L. × I.D.) 
under the same conditions employed for semipreparative HPLC, 
excepting the flow rate (1.0 mL/min). Concerning the racemic 
(±)-1d, the enantiomers were resolved by using a Chiralpak IC 
column (250 mm × 10 mm L. × I.D.) in semipreparative HPLC 
conditions, mobile phase consisted in a mixture of n-hexane/IPA 
95:5 v/v (flow rate 5.0 mL/min and Tcol. = 25 °C). The racemic 
(±)-1d was dissolved in the mobile phase (c = 60 mg/mL); each 
injection was 100 µL (process yield 79%). The enantiomeric 
excess, the UV, and ECD at 270 nm were determined by 
analytical HPLC with use of a Chiralpak IC column (250 mm × 
4.6 mm L. × I.D.) with a flow rate of 1.0 mL/min. The ECD 
spectra of chromatographically resolved (R)-1d and (S)-1d were 
recorded with the circular dichroism detector Jasco J710 CD 
spectrometer, using 2.1 × 10-5 M solutions in CHCl3.  
4.7 .1 .  Complex (S) -1a  
[α]D22 = -20.82 (c = 0.061 in CHCl3). 
4.7 .2 .  Complex (R)-1d  
[α]D20 = -16.22 (c = 0.018 in CHCl3). 
4.8. Single crystal XRD analysis of compound (S)-1a 
X-ray quality sample was selected at the optical microscope, 
resulting in pale-yellow prisms with dimensions of about 0.15 × 
0.10 × 0.10 mm. A crystal of (S)-1a, deriving from the first 
fraction obtained by enantiomer resolution by enantioselective 
HPLC, was mounted on a Bruker AXS APEXII CCD area-
detector diffractometer, at room temperature, for the unit cell 
determination and data collection. Graphite-monochromatized 
MoKα (λ = 0.71073 Å) radiation was used with the generator 
working at 50 kV and 30 mA. Orientation matrixes were initially 
obtained from least-squares refinement on ca. 300 reflections 
measured in three different ω regions, in the range 0° < θ < 23°; 
cell parameters were optimized on the position, determined after 
integration, of ca. 7000 reflections. The intensity data were 
retrieved in the full sphere, within the θ limits reported in the 
crystal data section, from 1080 frames collected with a 
sample−detector distance fixed at 5.0 cm (50 s frame−1; ω scan 
method, Δω = 0.5°). An empirical absorption correction was 
applied (SADABS) [24]. Crystal structure was solved by direct 
methods using SHELXT2017 and refined with SHELXL-2017/1 
[25] within the Wingx suite of programs [26]. Hydrogen atoms 
were riding on their carbon atoms. Anisotropic temperature 
factors were assigned to all non-hydrogen atoms. Crystal data 
collection and refinement parameters are listed in the 
Supplementary data and in the cif files. An ORTEP [27] view of 
the molecules with the full numbering scheme is given in Fig. S1 
and S2. Selected distances of bond lengths (Å) and angles (°) are 
given in Table S1, while atomic coordinates and displacement 
parameters are listed in the corresponding cif file. 
CCDC number 1885148 contains the full supplementary 
crystallographic data for this work. The latter can be obtained 
free of charge from the Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. Crystal data for 
compound name: C27H18FeO4, fw = 462.26 g mol
-1, orthorhombic 
P212121 (No. 19), a = 9.1937(5), b = 12.5845(6) and c = 
19.2348(10) Å; V = 2225.4(2) Å3; Z = 4; Mo-Kα λ = 0.71073 Å; 
T (K) 293(2); ρcalc =  1.38 g cm-3, μ(Mo-Kα) = 0.708 mm-1; θ 
range 1.934-31.685 °; Limiting indices -13≤ h ≤13, -18≤ k ≤18, -
28≤ l ≤27; data (unique), 6992 (6191); restraints, 0; parameters, 
289; Goodness-of-Fit on F2, 1.015; R1 and wR2 (I>2σ(I)), 0.0279 
and 0.0676; R1 and wR2 (all data), 0.0349 and 0.071; Flack 
parameter, 0.003(3); Largest Diff. Peak and Hole (e Å–3), 0.261 
and -0.212. 
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4.9. Simulation of ORD and CD spectra for the (R) enantiomer 
of 1d. 
The chiroptical properties of the enantiomers of 1d were 
estimated by molecular modelling calculations performed in two 
steps. In the first step the structure of the (R)-1d enantiomer was 
optimized at the B3LYP/6-31G* level of theory using the 
computer program SPARTAN 10v1.1.0 (Wavefunction Inc., 
18401 Von Karman Avenue, Suite 370, Irvine, CA 92612, USA). 
In the second step, by resorting to the Amsterdam Density 
Functional (ADF) package v. 2007.01, the optimized structure of 
(R)-1d was subjected to assessment of chiroptical properties, 
represented by the Optical Rotatory Dispersion (ORD) and the 
Electronic Circular Dichroism (ECD) spectra. Optical Rotation 
values []n at four different wavelengths n, in the range 320-589 
nm, were assessed using the BLYP method, employing the QZ4P 
large core basis set, as implemented in ADF. Always starting 
from the same optimized (R)-1d geometry, and again resorting to 
the ADF program, further calculations were also performed in 
order to simulate the relevant ECD spectrum. To this end, the set 
options were: single point calculation at the BLYP level of 
theory, employing the QZ4P large core basis set; 40 singlet and 
triplet excitations; diagonalization method: Davidson; velocity 
representation; scaling factor 1.00; peak width 31.0. It was found 
that, from comparison with the relevant experimental ECD and 
ORD spectra, the first-eluted enantiomer of 1d under the 
CSP/mobile phase conditions explored in the study had the R 
configuration. As a consequence, S configuration was assigned to 
the second-eluted enantiomer. 
4.10. General Procedure for the AH of ketones and ketimines 
Under argon atmosphere, the pre-catalyst was dispensed as 
DCM solution into oven-dried glass tubes fitted in an aluminum 
block inside a Schlenk tube. After removing DCM under vacuum, 
a 0.2 M solution of Me3NO in iPrOH (0.1 mL, 0.002 mmol) was 
dispensed. The resulting mixture was stirred at room temperature 
for 20 min, during which a deep orange color gradually 
developed. iPrOH (0.3 mL) and the substrate (0.2 mmol) were 
added in each vial. Each vial was capped with a Teflon septum 
pierced by a needle, the block was transferred into the autoclave, 
and stirring was started. After purging four times with hydrogen, 
the reaction was pressurized at 50 bar and heating was started 
(80 °C). The reactions were stirred for 22 h under hydrogen 
pressure at 80 °C. After cooling down to room temperature, the 
mixtures were filtered through a short part of celite and then 
analyzed for conversion and e.e. determination. When needed, 
product purification was carried out by flash column 
chromatography (hexane/AcOEt eluent mixtures). 
4.10.1 .  Analys is  o f  ke tone AH products  
The reaction mixtures were analyzed either by GC with a 
chiral column or by 1H NMR / enantioselective HPLC to measure 
conversion and enantiomeric excess. Absolute configurations 
were determined by comparing the elution order with previous 
data obtained with the same column, unless otherwise stated. 
4.10.1.1 1-Phenylethanol (P1) 
Conversion and e.e. were determined by chiral GC [4e,f]. 
Capillary column: MEGA-DEX DAC Beta, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 
25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 
95 °C for 20 min: tsubstrate = 4.76 min; tR = 10.36 min; tS = 12.39 
min. 
4.10.1.2 2,2,2-Trifluoro-1-phenylethan-1-ol (P3) [14] 
Conversion was determined by 1H NMR, the product was 
purified by flash chromatography (hexane/ethyl acetate = 9/1) 
and then analyzed by enantioselective HPLC [14]. 
HPLC conditions of e.e. determination: column: Chiralcel OD-H, 
0.8 mL/min, 95:5 hexane/iPrOH, λ = 210 nm, tS = 12.7 min, tR = 
21.5 min. 
GC conditions for determining conversion and e.e. were also 
established. Capillary column: MEGA-DEX DAC Beta, diacetyl-
tert-butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; 
length = 25 m; carrier: hydrogen; inlet pressure: 1 bar; oven 
temperature: 100 °C for 20 min: tsubstrate = 1.38 min; tS = 8.97 min, 
tR = 10.23 min; 
4.10.1.3 1-Phenylpropan-1-ol (P4) 
Conversion and e.e. were determined by chiral GC [4e,f]. 
Capillary column: MEGA-DEX DAC Beta, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 
25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 
120 °C for 15 min: tsubstrate = 2.91 min; tR = 3.45 min; tS = 3.58 
min. 
4.10.1.4 1-(Naphthalen-2-yl)ethan-1-one (P5) 
Conversion and e.e. were determined by chiral GC [4e,f]. 
Capillary column: MEGA-DEX DAC Beta, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 
25 m; carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 
150 °C for 20 min: tsubstrate = 9.23 min; tR = 14.89 min; tS = 16.07 
min. 
4.10.1.5 3,4-Dihydronaphthalen-2(1H)-one (P6) 
Conversion and e.e. were determined by chiral GC. Capillary 
column: MEGA-DEX DAC Beta, diacetyl-tert-butylsilyl-β-
cyclodextrin, 0.25 μm; diameter = 0.25 mm; length = 25 m; 
carrier: hydrogen; inlet pressure: 1 bar; oven temperature: 110 °C 
for 40 min: tR = 18.74 min; tS = 19.43 min; tsubstrate = 26.03 min. 
Absolute configurations were assigned by comparing the sign of 
optical rotation with literature data ([α]D23 = -51.4, c 0.70 in 
CHCl3, 82% e.e., S) [28]. 
 
4.10.2 .  Analys is  o f  ke t imine  AH products  
Conversions were determined by 1H NMR analysis of the 
crude reaction mixtures. After purification by flash 
chromatography (hexane/ethyl acetate/triethylamine, 89.6/10/0.4), 
the enantiomeric excesses were determined by HPLC analysis 
with a chiral column. 
4.10.2.1 4-Methoxy-N-(1-phenylethyl)aniline (P2) [4b] 
Column: Chiralpak AD-H, 0.8 mL/min, 97:3 hexane/iPrOH, λ 
= 210 nm, tR = 11.79 min, tS = 13.40 min. Absolute configuration 
was determined by comparison of the sign of optical rotation 
with literature data ([α]D15 = +8.5, c 0.9 in CHCl3, 98% e.e., R) 
[29]. 
4.10.2.2 4-Methoxy-N-(1-(naphthalen-2-yl)ethyl)aniline (P7) [4b] 
Column: Chiralcel OD-H, 0.5 mL/min, 9:1 hexane/iPrOH, λ = 
210 nm, tR = 15.70 min, tS = 17.73 min. Absolute configuration 
was determined by comparing the elution order with previous 
data obtained with the same column [29a]. 
4.10.2.3 4-Methoxy-N-(1-phenylpropyl)aniline (P8) [4b] 
Column: Chiralcel OD-H, 0.8 mL/min, 98:2 hexane/iPrOH, λ 
= 210 nm, tR = 10.66 min, tS = 11.90 min. Absolute configuration 
was determined by comparing the elution order with previous 
data obtained with the same column [29a]. 
4.10.2.4 4-Methoxy-N-(octan-2-yl)aniline (P9) [4b] 
Column: Phenomenex Cellulose 3 (5 μm), 0.5 mL/min, 100:1 
hexane/iPrOH, λ = 210 nm, tR = 14.93 min, tS = 15.57 min. 
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Absolute configuration was determined by comparing the elution 
order with previous data obtained with the same column [29a]. 
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